TABLE II.
Molecular Technologies for Assessing DNA and Genomic Defects, Using DNA From Mutagenized Parents and Their Children
| Technology | Major use | Applicable to single-cell analyses | Genomic resolution |
|---|---|---|---|
| PCR-based assays (sequencing or conformation)a,b | Single-gene assessment, methylation | Yes | Single base |
| Sequencing by hybridization | Allelotyping, mutation detection | Yes | Single base |
| End-sequence profiling (DNA and transcripts) | Structural rearrangements, large-scale resequencing, genome immortalization | No | Single base |
| Chromatin immunoprecipitation | Antibody-based multiprotein interrogation | Noa | Single protein |
| FISHb | Numerical and structural chromosomal aberrations | Yes | Megabase |
| CGH | Copy number gains and losses, allele-specific, methylation-specific | Possibly | 10–100 Kbp |
| High throughput LOH | LOH mapping, gene localization | Possibly | 10 Kbp |
| Optical mapping | Numerical and structural chromosomal aberrations | Yes | 100 bp |
| Genome subtraction | Mapping and cloning of lost or gained regions | Possibly | Megabase |
| Expression arrays | Comprehensive, semiquantitative expression, splicing | Yes | Single exon |
| SAGE (RNA and DNA) | Comprehensive, semiquantitative expression, splicing | No | Single gene |
| ChIP | DNA binding proteins, chromatin structure | No | Single gene |
| Protein lysate arrays | Antibody-based multiprotein interrogation | Noa | Single protein |
| 1D and 2D gel electrophoresis | Mutant protein detection | No | Single protein |
| Mass spectrometry | Qualitative protein composition | No | Single protein |
~100 cells are needed.
Technologies adapted to the analyses of genomic defects in human and animal sperm.